Thompson David E. Insider Trades

Insider Trading History

Track insider trading activity for Thompson David E.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $8.47 84,705 shares
Last Trade
Jan 05, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $8.39 83,910 shares
Last Trade
Dec 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $4.14 41,379 shares
Last Trade
Apr 27, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $2.88 28,846 shares
Last Trade
May 21, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $1.25 12,500 shares
Last Trade
Dec 30, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $1.25 12,500 shares
Last Trade
Jun 13, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $12.8 128,201 shares
Last Trade
Jun 24, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $10 100,000 shares
Last Trade
May 17, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $1.2 12,000 shares
Last Trade
May 08, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $0.776 7,758 shares
Last Trade
Nov 07, 2011 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $1.2 12,000 shares
Last Trade
Jun 30, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $0.353 3,531 shares
Last Trade
Jan 03, 2011 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $1.16 11,558 shares
Last Trade
Jan 03, 2011 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $1.2 12,000 shares
Last Trade
Sep 30, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Anthera Pharmaceuticals
Anthera Pharmaceuticals ANTH
Director
Holding Value $2.04 20,443 shares
Last Trade
Feb 23, 2010 Sale
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up